Cytek Biosciences
CTKB
CTKB
52 hedge funds and large institutions have $572M invested in Cytek Biosciences in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 9 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
23% less capital invested
Capital invested by funds: $744M → $572M (-$172M)
Holders
52
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$14.7M | |
| 2 | +$8.42M | |
| 3 | +$2.89M | |
| 4 |
Renaissance Technologies
New York
|
+$1.78M |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$1.27M |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$9.45M | |
| 3 | -$7.02M | |
| 4 |
Millennium Management
New York
|
-$3.83M |
| 5 |
CCM
CAAS Capital Management
New York
|
-$2.14M |